Stock Market

Home > Markets-Economic Times > Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19

Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19

June 13, 2020
The drug maker will obtain technology transfer from Gilead for manufacturing of the drug.

from Markets-Economic Times https://ift.tt/2AAqZhQ

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.